BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12727120)

  • 1. Development of a formulation that enhances gene expression and efficacy following intraperitoneal administration in rabbits and mice.
    Engler H; Machemer TR; Schluep T; Wen SF; Quijano E; Wills KN; Harper AE; Maneval DC; Conroy SE
    Mol Ther; 2003 Apr; 7(4):558-64. PubMed ID: 12727120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icodextrin enhances survival in an intraperitoneal ovarian cancer murine model utilizing gene therapy.
    Rocconi RP; Numnum MT; Zhu ZB; Lu B; Wang M; Rivera AA; Stoff-Khalili M; Alvarez RD; Curiel DT; Makhija S
    Gynecol Oncol; 2006 Dec; 103(3):985-9. PubMed ID: 16857247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of the adenoviral E1A deletion mutant dl922-947 in ovarian cancer: comparison with E1A wild-type viruses, bioluminescence monitoring, and intraperitoneal delivery in icodextrin.
    Lockley M; Fernandez M; Wang Y; Li NF; Conroy S; Lemoine N; McNeish I
    Cancer Res; 2006 Jan; 66(2):989-98. PubMed ID: 16424034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluid dynamics in man of an intraperitoneal drug delivery solution: 4% icodextrin.
    Hosie K; Gilbert JA; Kerr D; Brown CB; Peers EM
    Drug Deliv; 2001; 8(1):9-12. PubMed ID: 11280443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intraperitoneal 4% icodextrin solution on the healing of bowel anastomoses and laparotomy incisions in rabbits.
    Rodgers KE; Verco SJ; diZerega GS
    Colorectal Dis; 2003 Jul; 5(4):324-30. PubMed ID: 12814410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models.
    Nielsen LL; Gurnani M; Syed J; Dell J; Hartman B; Cartwright M; Johnson RC
    Hum Gene Ther; 1998 Mar; 9(5):681-94. PubMed ID: 9551616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
    Moberly JB; Mujais S; Gehr T; Hamburger R; Sprague S; Kucharski A; Reynolds R; Ogrinc F; Martis L; Wolfson M
    Kidney Int Suppl; 2002 Oct; (81):S23-33. PubMed ID: 12230479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of chemotherapy-induced intraperitoneal adhesion formation in rats by icodextrin at a range of concentrations.
    Conroy SE; Baines L; Rodgers K; Deviren F; Verco SJ
    Gynecol Oncol; 2003 Mar; 88(3):304-8. PubMed ID: 12648579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Icodextrin in peritoneal dialysis therapy].
    Grzegorzewska AE; Antczak-Jedrzejczak D
    Przegl Lek; 1999; 56(12):812-6. PubMed ID: 10789195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus.
    Anderson SC; Johnson DE; Harris MP; Engler H; Hancock W; Huang WM; Wills KN; Gregory RJ; Sutjipto S; Wen SF; Lofgren S; Shepard HM; Maneval DC
    Clin Cancer Res; 1998 Jul; 4(7):1649-59. PubMed ID: 9676839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of human colon tumor growth by adenoviral vector-mediated NK4 expression in an athymic mouse model.
    Jie JZ; Wang JW; Qu JG; Hung T
    World J Gastroenterol; 2007 Apr; 13(13):1938-46. PubMed ID: 17461494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies.
    Grace MJ; Xie L; Musco ML; Cui S; Gurnani M; DiGiacomo R; Chang A; Indelicato S; Syed J; Johnson R; Nielsen LL
    Am J Pathol; 1999 Dec; 155(6):1869-78. PubMed ID: 10595917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional effects of increasing dialysis dose by adding an icodextrin daytime dwell to Nocturnal Intermittent Peritoneal Dialysis (NIPD) in children.
    van Hoeck KJ; Rusthoven E; Vermeylen L; Vandesompel A; Marescau B; Lilien M; Schroder CH
    Nephrol Dial Transplant; 2003 Jul; 18(7):1383-7. PubMed ID: 12808177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of carotid neointimal formation after direct delivery of a recombinant adenovirus expressing glucagon-like peptide-1 in diabetic rats.
    Lim S; Lee GY; Park HS; Lee DH; Tae Jung O; Kyoung Min K; Kim YB; Jun HS; Hak Chul J; Park KS
    Cardiovasc Res; 2017 Feb; 113(2):183-194. PubMed ID: 27702762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution.
    Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 2000 Apr; 57(4):1704-12. PubMed ID: 10760106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental treatment of ovarian cancers by adenovirus vectors combining receptor targeting and selective expression of tumor necrosis factor.
    Murugesan SR; Akiyama M; Einfeld DA; Wickham TJ; King CR
    Int J Oncol; 2007 Oct; 31(4):813-22. PubMed ID: 17786312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer.
    Buller RE; Runnebaum IB; Karlan BY; Horowitz JA; Shahin M; Buekers T; Petrauskas S; Kreienberg R; Slamon D; Pegram M
    Cancer Gene Ther; 2002 Jul; 9(7):553-66. PubMed ID: 12082455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of human neutralizing antibodies on antitumor efficacy of an oncolytic adenovirus in a murine model.
    Tsai V; Johnson DE; Rahman A; Wen SF; LaFace D; Philopena J; Nery J; Zepeda M; Maneval DC; Demers GW; Ralston R
    Clin Cancer Res; 2004 Nov; 10(21):7199-206. PubMed ID: 15534093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.
    Yoon SK; Armentano D; Wands JR; Mohr L
    Cancer Gene Ther; 2001 Aug; 8(8):573-9. PubMed ID: 11571535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-responsive artificial promoter-mediated insulin gene transfer improves glucose control in diabetic mice.
    Han J; Kim EH; Choi W; Jun HS
    World J Gastroenterol; 2012 Nov; 18(44):6420-6; discussion p. 6425. PubMed ID: 23197887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.